þ T cells from old mice can proliferate in nonirradiated recipients. Transfer of labeled cells from aged donors into young recipients showed that proliferation of aged donor CD8 cells requires host cells that can both respond to interferon-c and produce interleukin-15. Reisolation of transferred CD8 cells from host mice showed that LAT (linker for activated T cells) translocation to the immunological synapse, and translocation of NF (nuclear factor)-jB to the nucleus were diminished in recovered CD8 T cells from old donors, whether they had divided in vivo or not. Cells able to proliferate in vivo could be isolated based on their unusually high levels of CD28 expression, but were found not to differ from other aged CD8 cells in their low levels of LAT and protein kinase C-theta (PKC-h) translocation to the immunological synapse. Thus in vivo proliferation of CD28 hi CD8 cells from aged mice cannot be attributed to retention of T-cell receptor signaling.
Memory CD8
þ T cells from old mice can proliferate in nonirradiated recipients. Transfer of labeled cells from aged donors into young recipients showed that proliferation of aged donor CD8 cells requires host cells that can both respond to interferon-c and produce interleukin-15. Reisolation of transferred CD8 cells from host mice showed that LAT (linker for activated T cells) translocation to the immunological synapse, and translocation of NF (nuclear factor)-jB to the nucleus were diminished in recovered CD8 T cells from old donors, whether they had divided in vivo or not. Cells able to proliferate in vivo could be isolated based on their unusually high levels of CD28 expression, but were found not to differ from other aged CD8 cells in their low levels of LAT and protein kinase C-theta (PKC-h) translocation to the immunological synapse. Thus in vivo proliferation of CD28 hi CD8 cells from aged mice cannot be attributed to retention of T-cell receptor signaling. P ERIPHERAL T-lymphocyte numbers are closely regulated by homeostatic mechanisms (1) (2) (3) (4) . The overall size and composition of the mature T-cell pool are likely to be controlled by multiple factors that influence both proliferation and survival. For instance, T cells undergo ''homeostatic'' proliferation upon adoptive transfer into Tcell-depleted syngeneic hosts (1) (2) (3) (4) . Recently, it has been shown that homeostasis of naïve T cells requires signals delivered by major histocompatibility complex (MHC) molecules and the cytokine interleukin (IL)-7 (5) (6) (7) (8) (9) (10) . In contrast to naïve T cells, homeostasis of memory T cells is known to be regulated independently of contact with MHC molecules (1, 3) . In addition to proliferating in response to T-cell depletion, memory T cells undergo intermittent cell division even under normal, i.e., nonlymphopenic conditions (11, 12) . Despite these control circuits, the proportion of memory T cells increases with age in both the CD4 and CD8 lineages (13) . Furthermore, the CD8 þ T-cell repertoire becomes less diverse in old age due to reduced thymic output (13) and accumulation of clonally expanded memory CD8 þ T cells (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) . These clones can represent as much as 80% of the CD8 þ T cells in rare individuals (22) . Expanded CD8 þ T cells clones appear in middle-aged mice, and longitudinal studies have shown that their frequency increases rapidly after the age of 18 months (27) . Most of these mouse CD8 þ T-cell clones are long lasting but nevertheless transient, and rarely, if ever, undergo malignant transformation. Hence, the T-cell repertoire of aged mice seems highly unstable, rather than terminally altered, although infrequent stable alterations can sometimes be seen (27) . However, the mechanisms that select and maintain such clonal expansions are not yet understood. We have recently shown (28) that the proportion of memory CD8 þ T cells able to proliferate in a nonirradiated recipient increases with age, and suggested that this age-dependent change is likely to contribute to the accumulation of expanded CD8 cell clones in old mice (14) .
Experiments with agents that stimulate the innate immune system, such as poly I:C and lipopolysaccharide (LPS), have shown that cytokines regulate the antigen-independent turnover of CD8 cells. Injecting these nonspecific stimulators into mice causes a brief burst of T-cell receptor (TCR)-independent (bystander) proliferation, largely restricted to a subset of CD8 þ cells with a memory (CD44 hi ) phenotype (29) (30) (31) (32) . Poly I:C and LPS stimulate T cells via production of interferons (IFNs), including both IFN-I and IFNc (31) . The inability of IFNs to stimulate purified T cells in vitro suggested that T-cell proliferation in vivo requires IFNinduced synthesis of another cytokine that, in turn, acts directly on CD44 hi CD8 þ cells. IL-15 seemed a likely candidate because IFNs and IFN-inducing agents induce strong IL-15 mRNA synthesis by antigen-presenting cells (APCs) in vitro (33) . Furthermore, IL-15 causes proliferation of purified CD8 þ CD44 hi T cells (but not CD4 þ CD44 hi T cells) and mimics the capacity of IFNs to stimulate these cells in vivo (34) . Most importantly, IL-15 has been implicated in the normal turnover of CD8 þ CD44 hi T cells in vivo (35) (36) (37) . Like memory phenotype CD8 þ T cells (38, 39) , cells of the expanded clones divide slowly in nonirradiated mice by a process that is probably antigen independent, driven by IL-15, and inhibited by IL-2 (39). However, the proliferating progeny of the large CD8 þ T cell clones accumulate, in vivo, more rapidly than the progeny of nonclonal CD8 þ T cells (39) . It has been speculated (39) that increased sensitivity to the stimulatory effects of IL-15 or lowered sensitive to the inhibitory effects of IL-2 may contribute to the accumulation of clonally expanded CD8 T cells in older mice. However, IL-2 does not seem to exert its inhibitory effects directly on memory CD8 þ T cells, but through intermediary cells (40) . We have recently shown that the memory CD8 þ T cells in old mice that are able to divide in nonirradiated recipients express high levels of CD28 both prior to and after injection into host recipients, and that these cells produce high levels of IFNc (28) . The experiments described in this article were designed to determine whether IFNc plays a role in the proliferation of memory CD8 þ T cells in old mice, and, in addition, to determine if those cells able to proliferate in vivo differed from other CD8 cells of aged mice in their relatively poor biochemical responses to TCR-mediated stimulation.
METHODS

Mice
Specific-pathogen-free male (BALB/cByJ 3 C57BL/6)F 1 (CByB6F1) and C57BL/6 (B6) mice were purchased from the National Institute on Aging's contract colonies at Harlan (Indianapolis, IN). The generation and description of B6.IL-15ÿ/ÿ, B6.IFNcÿ/ÿ, and B6.IFNcRÿ/ÿ have been described previously (35, 41) . B6.IL-15ÿ/ÿ mice were gifts from Dr. Jacques Peschon (Immunex Corp.). B6.IFNcÿ/ÿ and B6.IFNcRÿ/ÿ mice were purchased from The Jackson Laboratory. Unless otherwise stated, ''young'' mice were used at 4-8 months of age, and ''old'' mice were 18-25 months old. Mice were housed for at least 2 weeks after shipment in a specific-pathogen-free holding colony at the University of Michigan, and given free access to food and water. Sentinel animals from this colony were examined quarterly for serological evidence of viral infection; all such tests were negative during the experimental period. Mice that were found to have splenomegaly or macroscopically visible tumors at the time of sacrifice were not used for any experiments.
Cell Lines
B-cell hybridomas expressing monoclonal hamster antibodies (Abs) specific for murine CD3e (clone 145-2C11 [2C11]) or DNP (clone UC8) (American Type Culture Collection, Manassas, VA) were maintained in RPMI 1640 with 10% FCS (fetal calf serum) and 2 mM L-glutamine (RP-FC [RPMI-1640 medium with added FCS]) at 378C and 10% CO 2 . Flow cytometric analyses confirmed that both types of hybridoma cells not only express membrane-bound immunoglobulin (Ig) but also display significant surface levels of the costimulatory ligands B7 and ICAM-1 (unpublished data).
For each T-cell stimulation experiment, 2C11 and UC8 cells in log-phase growth were harvested, washed two times with prewarmed (378) HBSS, and then resuspended at 4 3 10 6 cells/ml in RP-FC.
Antibodies
All phycoerythrin (PE)-and CyChrome (CyC)-conjugated monoclonal antibodies (mAbs) were purchased from PharMingen (San Diego, CA). These included PE-labeled antibodies to mouse CD4, CD8, CD44, CD28, and immunoglobulin G (IgG) and CyC-labeled antibodies to mouse CD8, CD4, and IgG. Rabbit antimouse IgG was purchased from ICN (Costa Mesa, CA). Rat antimouse nuclear factor (NF)-jB (clone F-6), rat antimouse LAT (linker for activated T cells), rat antimouse protein kinase Ctheta (PKC-h), Alexa-594 goat antirat Fcc, and Alexa-594 donkey antigoat Fcc were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Purification of T Cells
To prepare T cells, spleens were gently rubbed between frosted glass slides to obtain single cell suspensions in HBSS containing 0.2% bovine albumin (HBSS-BSA). Erythrocytes were removed by centrifugation over Lympholyte-M (Cedarlane Laboratory, Ontario, Canada), and adherent cells and B cells were depleted by panning over rabbit antimouse IgG Ab-coated plates.
T-Cell Transfer, CFSE Staining, and Flow Cytometry Analysis
Purified cells were labeled with 5 lM CFSE (carboxy fluorescein diacetate succinimide ester) at 1 3 10 7 cells/ml in PBS/0.1% BSA for 10 minutes at 378C. Cells were then washed once with cold PBS/0.1% BSA and cold HBSS-BSA. CFSE-labeled cells were injected intravenously into the lateral tail vein of nonirradiated, syngeneic young mice in 200 ll of PBS/0.1% BSA; each recipient received an equal number of donor cells in any single experiment.
At day 12, cells from spleens and pooled lymph nodes (brachial, axillary, and inguinal) of recipient mice were isolated and stained with the appropriate cell surface marker antibodies for 30 minutes on ice. Cells were then washed with PBS/1% BSA and fixed with 4% paraformaldehyde for 30 minutes on ice. Cells were resuspended in PBS/1% BSA for flow cytometric analysis.
Purification of T Cells Based on In Vivo Proliferation History
To study the early phases of T-cell activation, T cells from aged donors and young donors (control) were labeled with CFSE as described above, injected into young recipients, recovered from the spleen and lymph nodes at day 12, and stained with anti-CD8 CyC. CD8 þ T cells were then purified by cell-sorting (using a FACSVantage instrument from Becton-Dickinson) on the basis of their CFSE signal. This approach yielded 3 populations of CFSElabeled CD8 þ T cells: 1) those from old donors that had not divided even once in the host (Old N-Div), 2) those from the old donors that had divided after injection (Old Div), and 3) those from the young donors that had not divided (Young N-Div). After sorting, cells were resuspended at 4 3 10 6 cells/ml in RP-FC, and then incubated at 378 for 15 minutes prior to further analysis. 
Analysis of T-Cell Signaling Molecules by Confocal Microscopy
Cells purified either by differences in CD28 expression or by differences in proliferative history in vivo were coincubated with equal volumes of 2C11 (anti-CD3) or UC8 (control) hybridoma cells at a 1:1 ratio. In some cases, where indicated, PMA (100 ng/ml) and ionomycin (500 ng/ml) were used to activate the cells. Cell mixtures were incubated at 378C for 30 minutes and then gently resuspended and spread (50-100 ll/slide) onto prewarmed poly-L-lysine-coated slides (Sigma, St. Louis, MO). Slides were incubated for another 30 minutes at 378 to promote cell attachment. The cells were then fixed in freshly prepared 3.7% formaldehyde/PBS for 15 minutes, and then finally washed three times with PBS. Slides were permeabilized with 0.1% Triton X/PBS for 10 minutes before three washes in PBS. Slides were then placed in blocking solution (1% BSA/0.1% NaN 3 /PBS) and stored at 48 for at least 24 hours. Slides were then stained with the appropriate rat antimouse antibody for 1 hour at 48C. The slides were then developed by incubation for 1 hour (each Ab) at 48C with Alexa-594 goat antirat Fcc and Alexa-594 donkey antigoat Fcc (NF-jB staining only); three washes with PBS were performed between Abs incubations. The slides were washed several times with PBS and mounted as described elsewhere (42) . We do not have numerical data on the proportion of cells from each group that could form a conjugate, although our qualitative impression is that this did not differ dramatically among the different experimental groups. Our conclusions are all based on the proportion of conjugates that go on to various stages of activation. We counted at least 100 conjugates (per sample) for each determination, using coded slides to ensure that the evaluations were done without knowledge of the specific experimental group.
Statistical Analyses
To estimate the proportion of injected cells that were able to proliferate in vivo, we used a quantitative analysis that has been described before (43) . It relies on the fact that the size of each subset of proliferating T cells is related to the size of the corresponding precursor subset by a function of 2 n , where n is the number of division cycles achieved in the recipient mice. Therefore, if a specific fluorescence peak corresponding to ''n'' mitotic divisions contains ''E'' cells, then the number of precursor T cells (''P'') which must have divided n times to generate them can be estimated as E divided by 2 n . The total number of original precursor cells needed to account for the observed progeny can be calculated as the sum of the ''P'' values for each of the peaks, one for each mitotic cycle, in the histogram. The percentage of cells in the recovered population that has given rise to a clone of proliferating progeny in vivo can then be calculated as the ratio of the sum of the ''P'' values to the total number of CFSE cells recovered (the sum of ''P'' plus the number of CFSE-positive nonproliferating cells).
Data are presented in the text and figures as mean 6 SEM (standard error of mean), and N indicates the number of individual experiments. Comparisons among different varieties of donor cells and recipient mice were made using analysis of variance.
RESULTS
We have previously shown using CFSE-tagged cells that the proportion of CD8 þ T cells able to proliferate in a nonirradiated recipient increases with age in mice (28) . This earlier work showed that the proliferating cells in aged mice were members of a CD8 memory subset, absent from young donors, and characterized by unusually high levels of cell surface CD28, and that these CD28 hi cells produced large amounts of IFNc both before and after transfer to recipient mice. Since IFNc has been implicated in the in vivo proliferation of memory CD8 þ T cells in some systems (29-32), we sought to explore the role of IFNc in the proliferation of CD8 þ T cells from old mice in nonirradiated recipients.
Proliferation of CD8 T Cells From Old Donors in IFNc and IFNcR Mutant Host Mice
IFNc has been shown to be involved in the induction of bystander proliferation of memory CD8 þ T cells in vivo (29) (30) (31) (32) . However, it has been reported that IFNc failed to cause proliferation of purified CD44
hi CD8 þ cells in vitro; in fact, under these conditions IFNc had a strong antiproliferative effect on T cells (33) . We therefore hypothesized that if IFNc produced by aged CD8 þ CD28 hi T cells played a role in their proliferation in vivo, it would not be in an autocrine fashion but rather by inducing the synthesis of a second cytokine that in turn acted directly on the CD44 hi CD8 þ cells. T cells from young and old B6 mice were labeled with CFSE and injected into nonirradiated young adult IFNc receptor knockout (IFNcRÿ/ÿ) or wild-type B6 mice. Twelve days later, T cells were isolated from the lymph nodes and spleens of the recipient mice and aliquots stained with PE-CD8. Figure 1 shows the results of a representative experiment. Summary statistics from a series of three such experiments are shown in the top panel of Figure 4 . In agreement with previous findings, many of the CFSElabeled cells from old donors recovered from lymph node (Figure 1 ) or spleen (not shown) of the wild-type recipient mice had CFSE levels that were 50% or 25% of that shown by the brightest CFSE-positive cells, indicating that these cells had divided once or twice in the previous 12-day period. However, CD8 þ T cells from old mice recovered from lymph node (Figure 1) or spleen (not shown) of the IFNcRÿ/ÿ recipient mice all had equally high levels of CFSE, indicating a failure to proliferate in the IFNcRÿ/ÿ mice. On average only 2% of the injected CD8 cells from old donors had been able to divide in IFNcRÿ/ÿ recipient mice, in comparison with 30% from CD8 T cells from old donors injected into wild-type recipients ( p ¼ .005). The mean proportion of CD8 T cells from young donors that were able to divide in wild-type recipients was 4%. This was significantly different than the percent of CD8 T cells from old donors that were able to divide in wild-type recipients (p ¼ .008). There was no statistical difference in the proliferation obtained from CD8 T cells from young and old donors injected into IFNcRÿ/ÿ mice (p ¼ .414). These data suggest that the proliferation of CD8 þ CD28 hi T cells from aged mice requires interaction with an IFNc-responsive cell from the host.
To determine if IFNc produced by host cells was involved in the expansion of aged CD8 cells in vivo, we injected CFSE-labeled T cells from young and old donors into IFNc knockout mice (IFNcÿ/ÿ). Figure 2 shows the results of a representative experiment. Summary statistics from a series of three such experiments are shown in the middle panel of Figure 4 . The data show that CD8 þ T cells from old mice were able to proliferate in IFNcÿ/ÿ mice. However, we observed a decrease in proliferation when these recipients were compared with wild-type recipients of the same CD8 cells. On average, 12% of the injected CD8 cells from old donors and recovered from recipient spleens had been able to divide in IFNcÿ/ÿ recipient mice, in comparison with 30% from CD8 T cells injected into wildtype recipients (p ¼ .012). There was a statistical difference in the proliferation obtained from CD8 T cells from young and old donors injected into IFNcÿ/ÿ mice ( p ¼ .002). In addition, the percent of proliferation of CD8 T cells from old donor was statistically different between IFNcÿ/ÿ and IFNcRÿ/ÿ recipient mice ( p ¼ .005). Similar results were seen in lymph node cells recovered from recipient mice. These data suggest that IFN production by the aged CD8 þ
CD28
hi T cells contributes to their own proliferation through the induction of an effector cytokine in the host, but also show that production of IFNc by host cells can amplify the proliferative response.
IL-15 has been previously implicated in the normal turnover of CD8 þ CD44 hi T cells in vivo (35) (36) (37) . To study the role of IL-15 in the CD8 þ T cell proliferation in vivo, we injected CFSE-labeled T cells from old and young donor mice into IL-15 knockout (IL-15ÿ/ÿ) recipient mice. Twelve days later, T cells were isolated from the lymph nodes and spleens of the recipient mice and aliquots stained with PE-CD8. Figure 3 shows the results of a representative experiment. Summary statistics from a series of three such experiments are shown in the bottom panel of Figure 4 . The data show that CD8 þ T cells fail to proliferate in IL-15ÿ/ÿ recipient mice, whether studied in the spleen or lymph node of host mice. We found that, on average, only 1.5% of CD8 T cells from old donors were able to divide in IL-15ÿ/ÿ recipient mice, in comparison with 30% of the CD8 T cells recovered from a wild-type recipient (spleen data; p ¼ .012). There was no statistical difference in the proliferation obtained from CD8 T cells from young and old donors injected into IL-15ÿ/ÿ mice ( p ¼ .06). In addition, there was no statistical difference in the percent of proliferation obtained from CD8 þ T cells injected into IL-15ÿ/ÿ mice when compared with CD8 T cells injected into IFNcRÿ/ÿ mice (p ¼ .06). These experiments suggest that host IL-15 producing cells are required for in vivo proliferation of aged CD8 T cells.
Some groups have reported (44) a decrease in the proportion of memory CD8 þ T cells upon injection of T cells into IL-15ÿ/ÿ mice. To determine if the lack of proliferation we observed in IL-15ÿ/ÿ mice was due to disappearance of memory CD8 þ T cells in the recipient mice, we injected CFSE-labeled T cells from old and young donor mice into IL-15ÿ/ÿ recipients. Twelve days later cells from the lymph nodes and spleens from recipient animals were stained with anti-CD8 and anti-CD44. Figure 5 shows the results of a representative experiment from a series of three experiments. Memory cells, indicated by relatively high levels of CD44 expression, are still present at day 12 in the IL-15 knockout recipients. The percent of memory cells is higher among CFSE cells recovered from old donors than in the mice receiving cells from young donors, as expected from the known increase with age in the proportion of CD8 memory T cells (13) . There were no consistent differences between young and old donors in the proportion of injected T cells that were recovered at day 12 from recipient mice ( Table 1) .
TCR-Mediated Signaling in CD8 T Cells Recovered After In Vivo Proliferation
Engagement of the TCR induces a series of biochemical events leading to T-cell differentiation and proliferation. These events include translocation of T-cell membrane signaling molecules, including Lck, Fyn, and PKC-h, toward the TCR/APC interaction synapse (45, 46) , followed by translocation of gene-activating molecules, including NF-jB, to the cell nucleus. Previous work from this laboratory has shown that virtually all CD4 T cells that are able to relocalize NF-AT (nuclear factor of activated T cells) in response to TCR-mediated stimuli are also able to translocate a wide range of synaptic molecules, but that the proportion of CD4 T cells that relocate NF-AT and synaptic molecules declines with age (47) . We speculated that the ability of the CD28 hi CD8 T cells to proliferate in vivo might reflect characteristic modes of signal transduction absent from nonproliferative T cells from old donors, as well as from young T cells. To clarify this, we used confocal immunofluorescence microscopy to follow redistribution to the nucleus of NF-jB, previously shown to play a critical role in the initiation of events leading to T-cell proliferation and differentiation (48) .
T cells from aged donors and young donors (control) were labeled with CFSE, injected into young recipients, recovered from the spleen and lymph nodes at day 12, and then purified by cell-sorting on the basis of their CFSE signal. This approach yielded three populations of CFSE-labeled cells: 1) cells, derived from old donors, that had not divided in the host, 2) cells derived from old donors that had divided at least once after injection, and 3) cells from the young donors, which do not divide in vivo. Recovered CFSE-labeled cells from young and old donor mice were incubated with live anti-CD3e (2C11) and anti-DNP (UC8, negative control) hybridoma cells to allow the formation of conjugates. Each T cell/2C11 or T-cell/UC8 conjugate was scored as positive (activated) or negative (nonactivated) for NF-jB relocalization to the nucleus, using coded slides to conceal age and subset information. Figure 6A shows representative images of responsive and unresponsive T cells, and Figure 6B shows a summary of the data. We found that approximately 70% of the conjugated CD8 cells derived from young donors were able to translocate NF-jB to the nucleus upon activation through the TCR, well above the baseline level (15%) seen in the negative control conjugates using UC8 (anti-DNP) hybridomas as mock stimulators. In contrast, NF-jB translocation was seen in fewer than 35% of the CFSE-tagged cells recovered from older donors, and the proportion did not differ appreciably between CD8 cells that had or had not divided in vivo. This decrease in NF-jB relocalization on CD8 þ T cells from old donors represented a defect specific for TCR-mediated activation processes, in that we did not observe any differences between cells recovered from young or old donors in responses triggered by phorbol myristate acetate (PMA) and ionomycin, which bypass the T-cell receptor complex. These stimuli induced NF-jB translocation in a large majority of recovered cells (;80%) regardless of CD8 subset or donor age ( Figure 6B, right panel) .
Similar experiments evaluated redistribution of the adapter protein LAT to the immunological synapse. LAT plays an essential role in the transmission of signals from the TCR complex to other key signaling proteins (49) (50) (51) , which then in combination initiate downstream events such as the activation of Ras, influx of Ca 2þ , and translocation of NF-jB to the nucleus. Figure 7 (top panels) shows examples of cells that do and do not redistribute LAT to the APC synapse. In agreement with our NF-jB data, we found a decrease in LAT relocalization to the immunological synapse in cells from both subsets of T cells from old donors when compared with cells from young donors. The bottom panel of Figure 7 shows a summary of the data. About 60% of conjugated CD8 cells from young donors exhibited redistribution of LAT into the immunological synapse, but the proportion of conjugated CD8 T cells with redistributed LAT was around 30% for both proliferating and nonproliferating CD8 subsets from old donors.
T-Cell Activation Signals in CD28 hi Precursors of Proliferating CD8 Cells From Old Mice
We wanted to see if similar activation defects are apparent in the CD28 hi subset of CD8 cells seen in aged mice, because this subset contains the precursors of the cells that are able to divide in vivo. To test this, CD8 T cells from young and old mice were sorted based on their CD28 levels and then examined for translocation to the synapse of LAT and the T-cell-specific protein kinase PKC-h. PKC-h is a key component in the TCR signaling cascade that leads to an upregulation of activating protein-1 (AP-1) (51) and has been shown by immunofluorescent methods to translocate to the immune synapse of TCR-transgenic T cells only in response to agonist peptides (53) . The sorting procedure produced 3 groups of cells: 1) CD8 þ CD28 hi T cells from old mice, 2) CD8 þ CD28 lo T cells from old mice, and 3) CD8 þ CD28 lo T cells from young mice. Cells of each subset were activated with 145-2C11 hybridoma cells or with UC8 hybridoma cells as a negative control. The top panel of Figure 8 shows the results of a series of two experiments comparing LAT redistribution in sorted CD8 cells from young and old mice after conjugation to 2C11 stimulators. 2C11 cells induce LAT redistribution in 60% of the conjugated CD8 þ CD28 lo from young mice, in 30% of the conjugated CD8 þ CD28 lo from old mice, and in 25% of the conjugated CD8 þ CD28 hi cells from old mice. Similarly, the frequency of activated T cells with redistributed PKC-h dropped significantly from 55% in CD8 þ CD28 lo cells from young mice to 28% and 24% in CD8 þ CD28 lo and CD8 þ CD28 hi cells from old mice, respectively.
DISCUSSION
The accumulation of large clones of CD8 þ T cells (14-26) in aging mice is likely to reflect alterations in the ability of some CD8 cells to regulate division or cell death in the face of homeostatic controls that are still poorly understood. We have recently reported that most of the CD8 þ T cells from old mice that can divide in vivo produce IFNc after isolation from their original host or after in vivo expansion in recipients. Since IFNc has been implicated in the proliferation of memory CD8 þ T cells in some systems (29-32), we explored its potential role in the proliferation of CD8 þ cells from old donors after transfer into normal recipients. IFNc fails to cause proliferation of purified CD44 hi CD8 þ cells in vitro; in fact, under these conditions IFNc had a strong antiproliferative effect on T cells (33) . Hence, we hypothesized that if IFNc were involved in CD8 cell proliferation in vivo, it would be through the induction of another cytokine, an effector cytokine that would act directly on CD44 hi CD8 þ cells. To study this hypothesis further, we have measured the proliferative capacity of T cells from young and old mice after transfer into IFNcRÿ/ÿ recipients by flow cytometry using the fluorescent dye CFSE. We found that the proliferation of CD8 þ T cells was prevented in IFNcRÿ/ÿ recipients. These results suggest that a response from host cells to IFNc is necessary for the proliferation of CD8 þ T cells in vivo. When we injected CFSE-labeled T cells into IFNcÿ/ÿ recipients, we found that CD8 þ T cells from old donors are still able to divide in vivo but to a lesser extent than in genetically normal hosts. These data indicate that production of IFNc by the injected CD8 þ CD28 hi T cells may promote the proliferation of these cells through the induction of an effector cytokine, but that IFNc produced from the host may be involved in amplifying the response. However, it is also possible that the absence of IFNc in these mutant mice leads to a diminished sensitivity of the IFN-responsive cell type needed to promote T-cell expansion in this model (54) . By injecting CFSE-labeled T cells into IL-15ÿ/ÿ recipients, we demonstrated that IL-15 is involved in the proliferation of CD8 þ T cells from old mice. Thus, IL-15 might be the effector cytokine produced by the host in response to IFNc. It has been reported that many cell types, including macrophages (but not T cells), can synthesize IL-15 (33) . IFNc has been shown to be a strong inducer of IL-15 mRNA in macrophages (33) .
IL-15 has been implicated as a key regulator in the survival and turnover of CD8 þ CD44 hi T cells in vivo (35) (36) (37) . Under steady-state conditions, continuous expansion of memory T cells may be limited by contact with specific cytokines, including IL-15. If so, a protracted increase in the level of these cytokines would be expected to cause the numbers of memory T cells to increase above normal. þ T cells from young and old mice were sorted based on their CD28 levels. Three groups of cells were obtained: 1) CD8 þ CD28 lo T cells from young mice, 2) CD8 þ CD28 lo T cells from old mice, and 3) CD8 þ CD28 hi T cells from old mice. Cells from the three groups were activated either with 145-2C11 hybridoma cells (anti-CD3; black) or with UC8 hybridomas (anti-DNP as control; white) to allow the formation of conjugates. We used immunofluorescence assays to follow the redistribution of LAT (top) or PKC-h (bottom) to the immunological synapse, using coded slides to conceal age and subset information. Each T cell/2C11 or T cell/UC8 conjugate was scored as positive or negative for LAT or PKC-h translocation to the immunological synapse. Figure 8 shows a summary of the results (N ¼ 2) (mean 6 SEM [standard error of mean]).
involve the activities of a suppressive population of IL-2-dependent regulatory CD25 þ CD4 þ T cells (40) . To clarify whether the CD8 cells whose proliferative abnormalities cause them to accumulate in aged mice were or were not normally responsive to antigenic stimulation, we used immunofluorescence assays to follow the redistribution of proteins involved in the TCR signaling cascade in cells from old and young donors that were or were not able to divide in a normal host. We found that activation-induced migration of LAT and NF-jB, two key proteins that act in TCR-initiated signaling pathways, occurred less frequently in CD8 T cells from old donors, whether they were able to divide in vivo or not, than in CD8 T cells from young donors. However, translocation of NF-jB could readily be induced in CD8 T cells from old donors when activated with PMA and ionomycin, suggesting that the defect in NF-jB movement was secondary to upstream signaling events in these cells. Our data suggest that intracellular signals are not generated or transmitted efficiently from the TCR complex to early acting components, including LAT, in CD8 T cells from old mice. Here, it is notable that, despite the fact that these CD8 cells from old donors were in a young host for 12 days, they still present defects in TCR activation when compared with CD8 T cells from young donors. This suggests that the defects induced by aging are intrinsic within the cells and are not corrected with a change of environment. We note that the data reported here document that CD8 T cells from aged mice exhibit at least some of the same defects in LAT, PKC-h, and NF-jB activation pathways that have previously been documented in studies of CD4 cells from older mice (42, 47) .
In a previous article, we reported a population of memory CD8 cells, with higher levels of CD28, present only in aged mice, from which emerged nearly all of the CD8 cells that were able to divide in vivo. We therefore asked whether CD8 þ CD28 hi T cells show the same defects as CD8 T cells from old donors recovered from recipients in the translocation of molecules to the immunological synapse. We found that CD8 þ CD28 hi T cells as well as CD8 þ CD28 lo T cells from old mice had a decline in the proportion of conjugates that redistribute LAT and PKC-h when compared with CD8 þ CD28 lo T cells from young donors. This argues against the idea that CD8 þ CD28 hi T cells might represent a subset of hyperresponsive cells that accumulate in old mice. Instead, they share the same age-associated alteration seen in the majority population of CD8 T cells in old mice. It has been reported that in humans, aging leads to a characteristic loss of CD28, predominantly among CD8 þ T cells (15, (18) (19) (20) . In humans, it is this CD28 ÿ T-cell population that is most typically susceptible to clonal expansion (15, (18) (19) (20) . This CD28 ÿ population consists of a subset of memory T cells with little proliferative response to mitogenic stimulation in vitro (56, 57) . Several reports suggest that they derive from a CD28 þ progenitor (57, 58) . It is not clear whether elderly humans have a specific CD8 þ subset, like the one we documented in aged mice, from which clonal expansions are derived, or whether such a precursor population has unusually high or low levels of CD28 expression.
The decline of LAT and PKC-h in CD8 T cells from old mice is not likely to be due to any alteration in T-cell expression of TCR or CD8. The cell surface concentrations of the TCR/CD3 complex (59-61) and of CD8 (61) have been shown not to be affected by aging in mice. Moreover, previous work from our laboratory showed no change with age in the proportion of CD8 cells that form conjugates with 2C11 stimulators (62) .
Phosphorylation of LAT allows it to bind to, and presumably help concentrate and orient, a number of SH2-containing proteins, including Grb2 and phospholipase C-c, that play a role in the propagation of downstream signals in the early phases of T-cell activation. PKC-h contributes to cell proliferation (53) , cell cycle progression (63) , and IL-2 production (64) (65) (66) . Immunofluorescence studies have shown that productive interaction between T-cell clones and APCs leads to PKC-h clustering in ;80% of the conjugated T cells. Interestingly, PKC-h clustering was not induced (53, 67) either by antibodies to the TCR complex or by APC-bearing antagonist peptides, nor did T-cell/APC interaction lead to the induction of clustering in any other PKC isoform in cloned T-cell lines. These data suggest that induction of PKC-h clustering might serve as a useful index for early activation events critical to the commitment of a T cell to entry into the mitotic cycle. Hence, we concluded that the defects we observed in LAT, PKC-h, and NF-jB redistribution in CD8 T cells from old mice are likely to contribute to downstream defects in T-cell activation. The molecular basis for the reduced susceptibility of these cells to homeostatic controls is, however, still undefined by the studies reported here.
